Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Busting the myth of methotrexate chronic hepatotoxicity.
Di Martino V, Verhoeven DW, Verhoeven F, Aubin F, Avouac J, Vuitton L, Lioté F, Thévenot T, Wendling D. Di Martino V, et al. Among authors: wendling d. Nat Rev Rheumatol. 2023 Feb;19(2):96-110. doi: 10.1038/s41584-022-00883-4. Epub 2022 Dec 23. Nat Rev Rheumatol. 2023. PMID: 36564450 Review.
Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.
Meyer O, de Bandt M, Berthelot JM, Cantagrel A, Combe B, Fautrel B, Flipo RM, Lioté F, Maillefert JF, Saraux A, Wendling D, Guillemin F, Le Loët X; Working Group for Therapeutic Strategies for Rheumatoid Arthritis. Meyer O, et al. Among authors: wendling d. Joint Bone Spine. 2007 Jan;74(1):73-8. doi: 10.1016/j.jbspin.2006.05.008. Epub 2006 Nov 29. Joint Bone Spine. 2007. PMID: 17194614
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM, Lioté F, Maillefert JF, Wendling D, Saraux A, Combe B, Le Loët X; Stratégies Thérapeutiques dans La Polyarthrite RhumatoIde Working Group; Club Rhumatismes et Inflammation; French Society of Rheumatology. Fautrel B, et al. Among authors: wendling d. Arthritis Rheum. 2009 Apr 15;61(4):425-34. doi: 10.1002/art.24588. Arthritis Rheum. 2009. PMID: 19333993 Free article.
[Paradoxical cutaneous manifestations during anti-TNF-alpha therapy].
Viguier M, Richette P, Bachelez H, Wendling D, Aubin F. Viguier M, et al. Among authors: wendling d. Ann Dermatol Venereol. 2010 Jan;137(1):64-71; quiz 63, 78-9. doi: 10.1016/j.annder.2009.10.003. Epub 2009 Dec 8. Ann Dermatol Venereol. 2010. PMID: 20110075 Review. French. No abstract available.
667 results